Deciphering the actions of antiparkinsonian and antipsychotic drugs on cAMP/DARPP-32 signaling
The basal ganglia are affected by several neuropsychiatric and neurodegenerative diseases, many of which are treated with drugs acting on the dopamine system. For instance, the loss of dopaminergic input to the striatum, which is the main pathological feature of Parkinson's disease (PD), is cou...
Saved in:
Main Authors: | Gilberto eFisone (Author), Alessandra eBonito-Oliva (Author), Michael eFeyder (Author) |
---|---|
Format: | Book |
Published: |
Frontiers Media S.A.,
2011-07-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
THE INTRACELLULAR SIGNALING MOLECULE DARPP-32 IS A MARKER FOR PRINCIPAL NEURONS IN THE CEREBELLUM AND CEREBELLUM-LIKE CIRCUITS OF ZEBRAFISH.
by: Lena Robra, et al.
Published: (2016) -
Multiple Facets of cAMP Signalling and Physiological Impact: cAMP Compartmentalization in the Lung
by: Martina Schmidt, et al.
Published: (2012) -
Cardiac cAMP: production, hydrolysis, modulation and detection
by: Cédric eBOULARAN, et al.
Published: (2015) -
Imaging alterations of cardiomyocyte cAMP microdomains in disease
by: Alexander eFroese, et al.
Published: (2015) -
Frontiers in the pharmacological manipulation of intracellular cAMP levels
by: George Scott Baillie, et al.
Published: (2016)